Exhibitors 2022



proBOX

proBOX

Biomedical device, named “proBOX”, for non-invasive, low-cost, in-home benign prostatic hyperplasia and prostate cancer early diagnosis and monitoring. The subject, whether forty or seventy year old, healthy or sick, who doesn’t want or cannot leave his house, can monitor the well-being or the pathological state of the organ, just by introducing a urine sample in proBOX. A multimarker analysis combined with artificial intelligence will give a result directly to the subject’s smartphone and, if connected to a cloud, to the doctor, who can then monitor his patient in real time. All at low cost, comfortably at home and without blood.

proBOX

Biagio Todaro, Nicolò Carta.

Biagio Todaro obtained his Master degree from the University of Chemistry and Pharmaceutical Technology in Florence (2017) and his Ph.D. from the University of Grenoble-Alpes in Bio-Chemistry (2020). After a Postdoctoral Research Fellow at the National Research Council in Bologna, Biagio is currently a Post-Doctoral Research Fellow at the Scuola Normale Superiore (Pisa). His work is mainly aimed at (i) synthesizing innovative nanostructures oriented to biomedical applications and (ii) developing portable device/technology, based on optical signals, for non-invasive detection of clinically relevant biomolecules in biological fluids.
Nicolò Carta obtained the bachelor and the master in Management Engineering at La Sapienza University of Rome in 2017 and 2019, after having spent one year in France by following the Erasmus+ program.
Nicolò is currently employed at KPMG Italy, as a Senior Consultant delivering IT Audit and Cybersecurity services. His main tasks are related to risk management, since his everyday activities are focused into the analysis of processes and identification of IT risks.


 Research
  D.35 (pav. D)
Back
 
Data updated on 2024-04-09 - 4.17.20 pm